Z-2387-2021 Class II Terminated

Recalled by Merge Healthcare, Inc. — Hartland, WI

FDA device recall Z-2387-2021 was initiated by Merge Healthcare, Inc. on Jul 23, 2021 and is designated Class II. Reason for recall: The firm identified a safety issue affecting the software associated with Merge Hemo versions 9.x and 10.x, used in combination with an HL7 lab interface. The recall status is terminated (terminated Aug 29, 2023). Affected quantity: 326 units.

Recall details

Product Type
Devices
Report Date
Sep 8, 2021
Initiation Date
Jul 23, 2021
Termination Date
Aug 29, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
326 units

Product description

Merge Hemo, Software packages 10.2, 10.3, and 10.4

Reason for recall

The firm identified a safety issue affecting the software associated with Merge Hemo versions 9.x and 10.x, used in combination with an HL7 lab interface.

Distribution pattern

US distribution

Code information

Version 10.2, UDI (01)00842000100430(10)10.2(11)190612 Version 10.3, UDI (01)00842000100874(10)10.3(11)200330 Version 10.4, UDI (01)00842000100966(10)10.4(11)210428

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2387-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2387-2021. Report a data issue: hello@regdatalab.com.